Skip to content

Author

Huseyin Dongelli

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Real-World Renal and Metabolic Outcomes of SGLT-2 Inhibitor Therapy in Patients with Type 2 Diabetes Mellitus

In routine care, SGLT2 inhibitor initiation was followed by changes in glycaemic, haematological, uric acid and albuminuria parameters that were similar in direction to those reported in randomised trials; the uncontrolled design and incomplete UACR data preclude causal inference.

Öykü Ünsal, Huseyin Dongelli, M. Ünal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.